AGT and triple-A syndrome: To examine the therapeutic potential of the Notch inhibitor (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester; DAPT) on the progression and stability of pre-established AAA, we used an AngII-induced mouse model of AAA in our studies.